Recurrent venous thromboembolism and bleeding during anticoagulation in patients with deep-vein thrombosis treated with vitamin K antagonists or direct oral anticoagulants: insights from the RIETE registry
Authors:
- Paolo PrandoniPPPaolo Prandoni
- Raffaele PesaventoRPRaffaele Pesavento
- Franca BiloraFBFranca Bilora
- Benjamin BrennerBBBenjamin Brenner
- Iria FranciscoIFIria Francisco
- Germán Sierra-PalomaresGSGermán Sierra-Palomares
- Ángeles FidalgoÁFÁngeles Fidalgo
- Jana HirmerovaJHJana Hirmerova
- Samuel FonsecaSFSamuel Fonseca
- Manuel MonrealMMManuel Monreal
- 28 August 2026
- journal article
- Published by Elsevier in European Journal of Internal Medicine
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Oral Anticoagulation and Risk of Adverse Clinical Outcomes in Venous ThromboembolismJAMA Internal Medicine, 2025
- On-treatment Comparative Effectiveness of Vitamin K Antagonists and Direct Oral Anticoagulants in GARFIELD-VTE, and Focus on Cancer and Renal DiseaseTH Open, 2022
- Effectiveness and Safety of Oral Anticoagulants in the Treatment of Acute Venous Thromboembolism: A Nationwide Comparative Cohort Study in FranceThrombosis and Haemostasis, 2022
- Antithrombotic Therapy for VTE DiseaseChest, 2021
- Direct oral anticoagulants and warfarin for venous thromboembolism treatment: Trends from 2012 to 2017Research and Practice in Thrombosis and Haemostasis, 2019
- Antithrombotic Therapy for VTE DiseaseChest, 2016
- Trends in the Management and Outcomes of Acute Pulmonary EmbolismJACC, 2016
- Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary EmbolismNew England Journal of Medicine, 2012
- Oral Rivaroxaban for Symptomatic Venous ThromboembolismNew England Journal of Medicine, 2010
- Dabigatran versus Warfarin in the Treatment of Acute Venous ThromboembolismNew England Journal of Medicine, 2009